메뉴 건너뛰기




Volumn 146, Issue 1-3, 2008, Pages 1-3

Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery

Author keywords

GIP; GLP 1; Incretin; Insulin

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INSULIN;

EID: 38149140788     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.09.032     Document Type: Article
Times cited : (10)

References (18)
  • 1
    • 12244311917 scopus 로고    scopus 로고
    • Overview of incretin hormones
    • Efendic S., and Portwood N. Overview of incretin hormones. Horm Metab Res 36 (2004) 742-746
    • (2004) Horm Metab Res , vol.36 , pp. 742-746
    • Efendic, S.1    Portwood, N.2
  • 2
    • 3042617876 scopus 로고    scopus 로고
    • The potential role of glucagon-like peptide 1 in diabetes
    • Meier J.J., and Nauck M.A. The potential role of glucagon-like peptide 1 in diabetes. Curr Opin Investig Drugs 5 (2004) 402-410
    • (2004) Curr Opin Investig Drugs , vol.5 , pp. 402-410
    • Meier, J.J.1    Nauck, M.A.2
  • 3
    • 15044341261 scopus 로고    scopus 로고
    • What do we know about the secretion and degradation of incretin hormones?
    • Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regul Pept 128 (2005) 117-124
    • (2005) Regul Pept , vol.128 , pp. 117-124
    • Deacon, C.F.1
  • 4
    • 0030031146 scopus 로고    scopus 로고
    • Gastric emptying and release of incretin hormones after glucose ingestion in humans
    • Schirra J., Katschinski M., Weidmann C., et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97 (1996) 92-103
    • (1996) J Clin Invest , vol.97 , pp. 92-103
    • Schirra, J.1    Katschinski, M.2    Weidmann, C.3
  • 5
    • 23944508999 scopus 로고    scopus 로고
    • Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects
    • Chaikomin R., Doran S., Jones K.L., et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 289 (2005) E504-E507
    • (2005) Am J Physiol Endocrinol Metab , vol.289
    • Chaikomin, R.1    Doran, S.2    Jones, K.L.3
  • 6
    • 3242675765 scopus 로고    scopus 로고
    • Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes
    • O'Donovan D.G., Doran S., Feinle-Bisset C., et al. Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 3431-3435
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 3431-3435
    • O'Donovan, D.G.1    Doran, S.2    Feinle-Bisset, C.3
  • 7
    • 0027281591 scopus 로고
    • Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects
    • Horowitz M., Edelbroek M.A., Wishart J.M., and Straathof J.W. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36 (1993) 857-862
    • (1993) Diabetologia , vol.36 , pp. 857-862
    • Horowitz, M.1    Edelbroek, M.A.2    Wishart, J.M.3    Straathof, J.W.4
  • 8
    • 34548382485 scopus 로고    scopus 로고
    • Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men
    • Pilichiewicz A.N., Chaikomin R., Brennan I.M., et al. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 293 (2007) E743-E753
    • (2007) Am J Physiol Endocrinol Metab , vol.293
    • Pilichiewicz, A.N.1    Chaikomin, R.2    Brennan, I.M.3
  • 9
    • 0029864391 scopus 로고    scopus 로고
    • The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects
    • Horowitz M., Cunningham K.M., Wishart J.M., Jones K.L., and Read N.W. The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects. Diabetologia 39 (1996) 481-486
    • (1996) Diabetologia , vol.39 , pp. 481-486
    • Horowitz, M.1    Cunningham, K.M.2    Wishart, J.M.3    Jones, K.L.4    Read, N.W.5
  • 10
    • 0028838030 scopus 로고
    • Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients
    • Herrmann C., Goke R., Richter G., Fehmann H.C., Arnold R., and Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56 (1995) 117-126
    • (1995) Digestion , vol.56 , pp. 117-126
    • Herrmann, C.1    Goke, R.2    Richter, G.3    Fehmann, H.C.4    Arnold, R.5    Goke, B.6
  • 12
    • 33645071360 scopus 로고    scopus 로고
    • Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
    • Theodorakis M.J., Carlson O., Michopoulos S., et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 290 (2006) E550-E559
    • (2006) Am J Physiol Endocrinol Metab , vol.290
    • Theodorakis, M.J.1    Carlson, O.2    Michopoulos, S.3
  • 13
    • 0032529111 scopus 로고    scopus 로고
    • Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin
    • Tolessa T., Gutniak M., Holst J.J., Efendic S., and Hellstrom P.M. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 102 (1998) 764-774
    • (1998) J Clin Invest , vol.102 , pp. 764-774
    • Tolessa, T.1    Gutniak, M.2    Holst, J.J.3    Efendic, S.4    Hellstrom, P.M.5
  • 14
    • 25844470444 scopus 로고    scopus 로고
    • Apical GLUT2: a major pathway of intestinal sugar absorption
    • Kellett G.L., and Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 54 (2005) 3056-3062
    • (2005) Diabetes , vol.54 , pp. 3056-3062
    • Kellett, G.L.1    Brot-Laroche, E.2
  • 15
    • 0034663719 scopus 로고    scopus 로고
    • The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane
    • Kellett G.L., and Helliwell P.A. The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane. Biochem J 350 Pt 1 (2000) 155-162
    • (2000) Biochem J , vol.350 , Issue.PART 1 , pp. 155-162
    • Kellett, G.L.1    Helliwell, P.A.2
  • 16
    • 0031929471 scopus 로고    scopus 로고
    • Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia
    • Byrne M.M., Pluntke K., Wank U., et al. Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia. Eur J Clin Invest 28 (1998) 72-78
    • (1998) Eur J Clin Invest , vol.28 , pp. 72-78
    • Byrne, M.M.1    Pluntke, K.2    Wank, U.3
  • 17
    • 33748460700 scopus 로고    scopus 로고
    • The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed
    • Little T.J., Doran S., Meyer J.H., et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 291 (2006) E647-E655
    • (2006) Am J Physiol Endocrinol Metab , vol.291
    • Little, T.J.1    Doran, S.2    Meyer, J.H.3
  • 18
    • 0001095690 scopus 로고    scopus 로고
    • Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients
    • Vilsboll T., Krarup T., Deacon C.F., Madsbad S., and Holst J.J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50 (2001) 609-613
    • (2001) Diabetes , vol.50 , pp. 609-613
    • Vilsboll, T.1    Krarup, T.2    Deacon, C.F.3    Madsbad, S.4    Holst, J.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.